AmpliGene India Biotech
PrivateLast Round
Accelerator
Jul 1, 2026
Total Funding Raised
$230,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AmpliGene India Biotech is a biotechnology company that develops molecular diagnostic solutions, including isothermal amplification technology and point-of-care testing systems for clinical, veterinary, and agricultural applications.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AmpliGene India Biotech Comparables
Compare AmpliGene India Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OptiGene Limited | 85% | |
| Achira Labs Private Limited | 80% | |
| Huwel Lifesciences | 80% |
AmpliGene India Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 1, 2026 |
AmpliGene India Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centre for Cellular and Molecular Platforms | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
$230K raised from Centre for Cellular and Molecular Platforms and global-amr-innovation-fund.
AmpliGene India Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AmpliGene India Biotech's valuation, stock price, and market status.
Is AmpliGene India Biotech a public or private company?
AmpliGene India Biotech is a private company.
What is the current stock price of AmpliGene India Biotech?
AmpliGene India Biotech is a private company, so its shares have no public market price. Caplight tracks AmpliGene India Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AmpliGene India Biotech worth (valuation)?
Valuation information for AmpliGene India Biotech is not publicly available.
Can I buy AmpliGene India Biotech stock?
AmpliGene India Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AmpliGene India Biotech's last funding round?
AmpliGene India Biotech's most recent funding round was Accelerator on July 1, 2026.
Who are the main investors in AmpliGene India Biotech?
Key investors in AmpliGene India Biotech include Centre for Cellular and Molecular Platforms.
Will AmpliGene India Biotech IPO soon?
No public IPO plans have been announced for AmpliGene India Biotech.
How can I track AmpliGene India Biotech secondary market activity?
Caplight tracks bids, offers, and trades in AmpliGene India Biotech's shares on secondary markets.